BMRN Competitors & Alternatives
Compare Biomarin Pharmaceutical Inc with similar stocks in the same industry
Biotechnology
BMRN
Main Stock$55.95
Tradestie Score
73
Market Cap
$10.53B
P/E Ratio
153.1
Revenue Growth
0.2%
Analyst Upside
+63.6%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$243.37
|
$12.36B | 18.3 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$64.53
|
$11.09B | 20.6 | 29 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.49
|
$10.76B | - | 57 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$200.10
|
$10.74B | - | 41 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$42.93
|
$10.49B | - | 61 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$68.56
|
$10.22B | - | 58 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$434.24
|
$10.01B | - | 48 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.55
|
$9.33B | 62.6 | 53 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$85.86
|
$8.88B | 256.0 | 46 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$125.63
|
$8.77B | 36.5 | 32 | Compare |
More BMRN Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry